| Dr Dana A Osborne, MD | |
|
2525 E Broadway St Ste 202, Helena, MT 59601-8049 | |
| (406) 457-4180 | |
| Not Available |
| Full Name | Dr Dana A Osborne |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 23 Years |
| Location | 2525 E Broadway St Ste 202, Helena, Montana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831388644 | NPI | - | NPPES |
| 12461 | Other | MT | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 12461 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Valley Hospital | Whitefish, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Logan Health - Whitefish | 9335033687 | 43 |
News Archive
Overexpression of CRIPTO1 may explain intrinsic tyrosine kinase inhibitor resistance in around 10% of patients with non-small-cell lung cancer and endothelial growth factor receptor mutations, research indicates.
Treating high-risk heart patients with a single, high dose of radiation therapy can dramatically reduce episodes of rapid, abnormal heartbeats for more than two years, offering hope to patients who have exhausted other treatment options.
Spinifex Pharmaceuticals, an Australian pain drug development company, today announced it has secured venture capital investment of A$12 million from GBS Venture Partners Limited, Brandon Capital Partners and Uniseed to fund the development of its pain management drug, EMA401.
Physiotherapy may be an effective complementary therapy to laxatives for treating constipation in children, research indicates.
› Verified 7 days ago
| Entity Name | Community Hospital Of Anaconda |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538597703 PECOS PAC ID: 8123938974 Enrollment ID: O20031119000745 |
News Archive
Overexpression of CRIPTO1 may explain intrinsic tyrosine kinase inhibitor resistance in around 10% of patients with non-small-cell lung cancer and endothelial growth factor receptor mutations, research indicates.
Treating high-risk heart patients with a single, high dose of radiation therapy can dramatically reduce episodes of rapid, abnormal heartbeats for more than two years, offering hope to patients who have exhausted other treatment options.
Spinifex Pharmaceuticals, an Australian pain drug development company, today announced it has secured venture capital investment of A$12 million from GBS Venture Partners Limited, Brandon Capital Partners and Uniseed to fund the development of its pain management drug, EMA401.
Physiotherapy may be an effective complementary therapy to laxatives for treating constipation in children, research indicates.
› Verified 7 days ago
| Entity Name | St. Peter's Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205025145 PECOS PAC ID: 7911814926 Enrollment ID: O20031204001245 |
News Archive
Overexpression of CRIPTO1 may explain intrinsic tyrosine kinase inhibitor resistance in around 10% of patients with non-small-cell lung cancer and endothelial growth factor receptor mutations, research indicates.
Treating high-risk heart patients with a single, high dose of radiation therapy can dramatically reduce episodes of rapid, abnormal heartbeats for more than two years, offering hope to patients who have exhausted other treatment options.
Spinifex Pharmaceuticals, an Australian pain drug development company, today announced it has secured venture capital investment of A$12 million from GBS Venture Partners Limited, Brandon Capital Partners and Uniseed to fund the development of its pain management drug, EMA401.
Physiotherapy may be an effective complementary therapy to laxatives for treating constipation in children, research indicates.
› Verified 7 days ago
| Entity Name | Logan Health - Whitefish |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396710851 PECOS PAC ID: 9335033687 Enrollment ID: O20040209001144 |
News Archive
Overexpression of CRIPTO1 may explain intrinsic tyrosine kinase inhibitor resistance in around 10% of patients with non-small-cell lung cancer and endothelial growth factor receptor mutations, research indicates.
Treating high-risk heart patients with a single, high dose of radiation therapy can dramatically reduce episodes of rapid, abnormal heartbeats for more than two years, offering hope to patients who have exhausted other treatment options.
Spinifex Pharmaceuticals, an Australian pain drug development company, today announced it has secured venture capital investment of A$12 million from GBS Venture Partners Limited, Brandon Capital Partners and Uniseed to fund the development of its pain management drug, EMA401.
Physiotherapy may be an effective complementary therapy to laxatives for treating constipation in children, research indicates.
› Verified 7 days ago
| Entity Name | Logan Health - Whitefish |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1396710851 PECOS PAC ID: 9335033687 Enrollment ID: O20061104000679 |
News Archive
Overexpression of CRIPTO1 may explain intrinsic tyrosine kinase inhibitor resistance in around 10% of patients with non-small-cell lung cancer and endothelial growth factor receptor mutations, research indicates.
Treating high-risk heart patients with a single, high dose of radiation therapy can dramatically reduce episodes of rapid, abnormal heartbeats for more than two years, offering hope to patients who have exhausted other treatment options.
Spinifex Pharmaceuticals, an Australian pain drug development company, today announced it has secured venture capital investment of A$12 million from GBS Venture Partners Limited, Brandon Capital Partners and Uniseed to fund the development of its pain management drug, EMA401.
Physiotherapy may be an effective complementary therapy to laxatives for treating constipation in children, research indicates.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dana A Osborne, MD Po Box 6369, Helena, MT 59604-6369 Ph: (406) 447-2823 | Dr Dana A Osborne, MD 2525 E Broadway St Ste 202, Helena, MT 59601-8049 Ph: (406) 457-4180 |
News Archive
Overexpression of CRIPTO1 may explain intrinsic tyrosine kinase inhibitor resistance in around 10% of patients with non-small-cell lung cancer and endothelial growth factor receptor mutations, research indicates.
Treating high-risk heart patients with a single, high dose of radiation therapy can dramatically reduce episodes of rapid, abnormal heartbeats for more than two years, offering hope to patients who have exhausted other treatment options.
Spinifex Pharmaceuticals, an Australian pain drug development company, today announced it has secured venture capital investment of A$12 million from GBS Venture Partners Limited, Brandon Capital Partners and Uniseed to fund the development of its pain management drug, EMA401.
Physiotherapy may be an effective complementary therapy to laxatives for treating constipation in children, research indicates.
› Verified 7 days ago
Natalie Gonzales, D.O. Surgery Medicare: Not Enrolled in Medicare Practice Location: 400 Saddle Dr, Helena, MT 59601 Phone: 406-442-0099 Fax: 406-422-0208 | |
Dr. Debra Anne Kontny, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 3130 Saddle Dr, Suite 2, Helena, MT 59601 Phone: 406-513-1962 | |
Dr. William Joseph Harper, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 400 Saddle Dr, Helena, MT 59601 Phone: 406-442-0099 Fax: 406-442-0208 | |
Dr. Dale Gilman Johnson, MD Surgery Medicare: Medicare Enrolled Practice Location: 828 S California St, Helena, MT 59601 Phone: 406-443-1579 | |
John E Galt, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2525 E Broadway St Ste 200, Helena, MT 59601 Phone: 406-457-4180 | |
Emily Julia Bubbers, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2550 E Broadway St, Helena, MT 59601 Phone: 406-457-4180 | |
Dr. Alissa D Abentroth, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2525 E Broadway St Ste 200, Helena, MT 59601 Phone: 406-457-4180 |